Michael Scolaro

Michael Scolaro

Sep 08, 2017

Group 6 Copy 160
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can Data Management Tools Improve Research Efficiency and Reproducibility?

Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

What can we do to improve survival in babies with respiratory distress in Bangladesh?

Respiratory Distress is a treatable disease which kills hundreds of thousands of babies every year. Most of...

Improving Collaborations for Neglected Tropical Diseases

Neglected tropical diseases (NTDs) infect over a billion of the poorest people in the world, yet only a tiny...

Backer Badge Funded